Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1344 (LINC01344) is a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs (lncRNAs) defined as autonomously transcribed RNA molecules longer than 200 nucleotides that do not overlap annotated protein-coding genes[1][3]. LincRNAs are typically involved in a variety of regulatory processes, including epigenetic regulation, chromatin remodeling, gene expression modulation, and transcript stabilization, often functioning in a tissue-specific manner[1][3][5]. Although many lincRNAs have been linked to gene regulatory roles or disease states, there is currently no direct evidence in the literature connecting LINC01344 to a specific biological function, disease, or drug targeting. Thus, LINC01344 is considered part of the broader class of non-coding regulatory RNAs, whose specific cellular activities may be context-dependent but remain largely uncharacterized for this molecule.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1344 (LINC01344).